The critical role of gut-brain axis microbiome in mental disorders

No abstract is available for this paper.

• Publication year

  2023

• Venue

  Metabolic brain disease

• Publication date

  2023-07-12

• Fields of study

  Biology, Medicine, Psychology

• Identifiers
  DOI 10.1007/s11011-023-01248-wPMID 37436588
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Role of the gut–brain axis in energy and glucose metabolism

  2022cited by this paper
• Are We What We Eat? Impact of Diet on the Gut–Brain Axis in Parkinson’s Disease

  2022cited by this paper
• Brain-gut-microbiota axis in Parkinson's disease: a historical review and future perspective.

  2022cited by this paper
• The Microbiome-Gut-Brain Axis and Resilience to Developing Anxiety or Depression under Stress

  2021cited by this paper
• The role of gut dysbiosis in Parkinson's disease: mechanistic insights andtherapeutic options.

  2021influential reference
• Probiotics for Alzheimer’s Disease: A Systematic Review

  2021cited by this paper
• The gut-brain axis and Parkinson disease: clinical and pathogenetic relevance

  2021cited by this paper
• Irritable Bowel Syndrome, Depression, and Neurodegeneration: A Bidirectional Communication from Gut to Brain

  2021influential reference
• Diet-Microbiota-Brain Axis in Alzheimer’s Disease

  2021cited by this paper
• The Microbiota-Gut-Brain Axis: From Motility to Mood.

  2021cited by this paper
• Diet and the Microbiota-Gut-Brain Axis: Sowing the Seeds of Good Mental Health.

  2021cited by this paper
• Endoplasmic reticulum stress, an important factor in the development of Parkinson's disease.

  2020cited by this paper
• Microbiota-Gut-Brain Axis: New Therapeutic Opportunities.

  2020cited by this paper
• The Microbiota–Gut–Brain Axis and Alzheimer’s Disease: Neuroinflammation Is to Blame?

  2020cited by this paper
• Landscapes of bacterial and metabolic signatures and their interaction in major depressive disorders

  2020influential reference
• The impact of the microbiota-gut-brain axis on Alzheimer's disease pathophysiology.

  2020cited by this paper
• The Need for More and Better Testing for COVID-19.

  2020cited by this paper
• Increased iron-deposition in lateral-ventral substantia nigra pars compacta: A promising neuroimaging marker for Parkinson's disease

  2020cited by this paper
• Future of Probiotics and Prebiotics and the Implications for Early Career Researchers

  2020cited by this paper
• Crosstalk between the microbiota-gut-brain axis and depression

  2020cited by this paper
• Assessment of Probiotics Mixture on Memory Function, Inflammation Markers, and Oxidative Stress in an Alzheimer's Disease Model of Rats

  2020cited by this paper
• d-glutamate and Gut Microbiota in Alzheimer’s Disease

  2020cited by this paper
• Probiotics Alleviate the Progressive Deterioration of Motor Functions in a Mouse Model of Parkinson’s Disease

  2020cited by this paper
• Diagnosis and Treatment of Parkinson Disease: A Review.

  2020cited by this paper
• Gut microbiota differences between healthy older adults and individuals with Parkinson's disease: A systematic review.

  2020cited by this paper
• The differential effects of fatty acids on enterocytic abundance of amyloid-beta

  2019cited by this paper
• Irritable Bowel Syndrome Subtypes: New Names for Old Medical Conditions

  2019cited by this paper
• New insights into irritable bowel syndrome: from pathophysiology to treatment

  2019cited by this paper
• The regulation of glutamic acid decarboxylases in GABA neurotransmission in the brain

  2019cited by this paper
• Gut Microbiota in Patients With Irritable Bowel Syndrome-A Systematic Review.

  2019cited by this paper
• Oxidative stress and α-synuclein conspire in vulnerable neurons to promote Parkinson's disease progression.

  2019cited by this paper
• Altered Gut Microbiome in Parkinson’s Disease and the Influence of Lipopolysaccharide in a Human α-Synuclein Over-Expressing Mouse Model

  2019cited by this paper
• Schizophrenia, Dopamine and the Striatum: From Biology to Symptoms

  2019cited by this paper
• Glutamatergic Signaling Along The Microbiota-Gut-Brain Axis

  2019cited by this paper
• Impaired dopamine metabolism in Parkinson’s disease pathogenesis

  2019cited by this paper
• The Alzheimer's Disease Clinical Spectrum: Diagnosis and Management.

  2019cited by this paper
• Alterations in fecal short-chain fatty acids in patients with irritable bowel syndrome

  2019cited by this paper
• Cell type-specific gene expression patterns associated with posttraumatic stress disorder in World Trade Center responders

  2019cited by this paper
• The microbiome-gut-brain axis in acute and chronic brain diseases.

  2019cited by this paper
• Contributions of Gut Bacteria and Diet to Drug Pharmacokinetics in the Treatment of Parkinson's Disease

  2019cited by this paper
• Brain-Gut-Microbiota Axis in Alzheimer’s Disease

  2019cited by this paper
• Key role of gut microbiota in anhedonia-like phenotype in rodents with neuropathic pain

  2019cited by this paper
• SCFAs strongly stimulate PYY production in human enteroendocrine cells

  2018cited by this paper
• Intestinal Crosstalk between Microbiota and Serotonin and its Impact on Gut Motility.

  2018cited by this paper
• The contribution of culturomics to the repertoire of isolated human bacterial and archaeal species

  2018cited by this paper
• Longitudinal Analysis of Fecal Microbiome and Pathologic Processes in a Rotenone Induced Mice Model of Parkinson’s Disease

  2018cited by this paper
• Fecal Clostridiales distribution and short‐chain fatty acids reflect bowel habits in irritable bowel syndrome

  2018cited by this paper
• Biomarkers for Depression: Recent Insights, Current Challenges and Future Prospects.

  2018cited by this paper
• Unraveling gut microbiota in Parkinson's disease and atypical parkinsonism

  2018cited by this paper
• A Functional Application of the Gut-Brain Axis: a Proposed Nutrition Intervention for the Treatment of Depression

  2018cited by this paper
• What Is the Evidence that Parkinson’s Disease Is a Prion Disorder, Which Originates in the Gut?

  2018influential reference
• Stomaching the Possibility of a Pathogenic Role for Helicobacter pylori in Parkinson’s Disease

  2018cited by this paper
• The Neuroendocrinology of the Microbiota-Gut-Brain Axis: A Behavioural Perspective.

  2018cited by this paper
• The Gut Microbiome Alterations and Inflammation-Driven Pathogenesis of Alzheimer’s Disease—a Critical Review

  2018cited by this paper
• Linking the Gut Microbiota to a Brain Neurotransmitter.

  2018cited by this paper
• Microbiota-Brain-Gut Axis and Neurodegenerative Diseases

  2017cited by this paper
• Microbiota and Aging. A Review and Commentary.

  2017cited by this paper
• Variations in gut microbiota and fecal metabolic phenotype associated with depression by 16S rRNA gene sequencing and LC/MS‐based metabolomics

  2017influential reference
• New insights into the pathogenesis and treatment of irritable bowel syndrome.

  2017cited by this paper
• Autophagy impairment in Parkinson's disease.

  2017cited by this paper
• The nasal and gut microbiome in Parkinson's disease and idiopathic rapid eye movement sleep behavior disorder

  2017cited by this paper
• Reduction of Abeta amyloid pathology in APPPS1 transgenic mice in the absence of gut microbiota

  2017influential reference
• Antibiotic-induced perturbations in microbial diversity during post-natal development alters amyloid pathology in an aged APPSWE/PS1ΔE9 murine model of Alzheimer’s disease

  2017cited by this paper
• The effects of probiotics on depressive symptoms in humans: a systematic review

  2017cited by this paper
• Anxiety, Depression, and the Microbiome: A Role for Gut Peptides

  2017influential reference
• Parkinson's disease psychosis: presentation, diagnosis and management.

  2017cited by this paper
• Differences in gut microbial composition correlate with regional brain volumes in irritable bowel syndrome

  2017cited by this paper
• β-Amyloid and the Pathomechanisms of Alzheimer’s Disease: A Comprehensive View

  2017influential reference
• Role of the peripheral innate immune system in the development of Alzheimer's disease

  2017cited by this paper
• Early life diets with prebiotics and bioactive milk fractions attenuate the impact of stress on learned helplessness behaviours and alter gene expression within neural circuits important for stress resistance

  2017cited by this paper
• Microbiome, probiotics and neurodegenerative diseases: deciphering the gut brain axis

  2017cited by this paper
• The Microbiome-Gut-Brain Axis in Health and Disease.

  2017cited by this paper
• NLRP3 gene knockout blocks NF‐&kgr;B and MAPK signaling pathway in CUMS‐induced depression mouse model

  2017cited by this paper
• Neurotransmitters: The Critical Modulators Regulating Gut–Brain Axis

  2017cited by this paper
• Our Gut Microbiome: The Evolving Inner Self.

  2017cited by this paper
• Expert consensus document: The International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of prebiotics

  2017cited by this paper
• The role of microbial amyloid in neurodegeneration

  2017cited by this paper
• Association of brain amyloidosis with pro-inflammatory gut bacterial taxa and peripheral inflammation markers in cognitively impaired elderly.

  2017cited by this paper
• Kynurenine pathway metabolism and the microbiota‐gut‐brain axis

  2017cited by this paper
• Identification of an Intestinal Microbiota Signature Associated With Severity of Irritable Bowel Syndrome.

  2017cited by this paper
• Lost in translation? The potential psychobiotic Lactobacillus rhamnosus (JB-1) fails to modulate stress or cognitive performance in healthy male subjects.

  2017cited by this paper
• Gut microbiome alterations in Alzheimer’s disease

  2017cited by this paper
• Brain-Gut-Microbiota Axis and Mental Health

  2017cited by this paper
• Transferring the blues: Depression-associated gut microbiota induces neurobehavioural changes in the rat.

  2016cited by this paper
• Association between Parkinson's Disease and Helicobacter Pylori

  2016cited by this paper
• The role of diet on gut microbiota composition.

  2016influential reference
• Antibiotic-induced perturbations in gut microbial diversity influences neuro-inflammation and amyloidosis in a murine model of Alzheimer’s disease

  2016cited by this paper
• Possible association of Bifidobacterium and Lactobacillus in the gut microbiota of patients with major depressive disorder.

  2016cited by this paper
• Molecular biomarkers of depression.

  2016cited by this paper
• Gut microbiome remodeling induces depressive-like behaviors through a pathway mediated by the host’s metabolism

  2016cited by this paper
• Short Chain Fatty Acids Prevent High-fat-diet-induced Obesity in Mice by Regulating G Protein-coupled Receptors and Gut Microbiota

  2016cited by this paper
• Fermentable carbohydrate stimulates FFAR2-dependent colonic PYY cell expansion to increase satiety

  2016cited by this paper
• Short chain fatty acids and gut microbiota differ between patients with Parkinson's disease and age-matched controls.

  2016cited by this paper
• Inflammatory Response in the CNS: Friend or Foe?

  2016cited by this paper
• Evidence that independent gut‐to‐brain and brain‐to‐gut pathways operate in the irritable bowel syndrome and functional dyspepsia: a 1‐year population‐based prospective study

  2016cited by this paper
• Assessing anhedonia in depression: Potentials and pitfalls.

  2016cited by this paper
• Role of gut microbiota and nutrients in amyloid formation and pathogenesis of Alzheimer disease.

  2016cited by this paper
• Stress and the Microbiota–Gut–Brain Axis in Visceral Pain: Relevance to Irritable Bowel Syndrome

  2016cited by this paper
• Enteroendocrine cells: a review of their role in brain–gut communication

  2016cited by this paper
• Insulin resistance and Parkinson's disease: A new target for disease modification?

  2016cited by this paper

• Inflammatory Cytokines as a Shared Pathophysiological Pathway in Depression and Chronic Insomnia: A Narrative Review of Mechanisms and Clinical Implications

  2026cites this paper
• Fistula in Crohn’s disease: classification, pathogenesis, and treatment options

  2025cites this paper
• Faecal Microbiota Transplantation Modulates Morphine Addictive‐Like Behaviours Through Hippocampal Metaplasticity

  2025cites this paper
• Ebastine in combination with low-dose antidepressants for refractory irritable bowel syndrome: A randomized controlled trial.

  2025cites this paper
• Ginsenoside Rg3 alleviates brain damage caused by chlorpyrifos exposure by targeting and regulating the microbial-gut-brain axis.

  2025cites this paper
• Gut Microbiome Composition Changes During Insomnia Treatment with Lemborexant

  2025cites this paper
• Molecular pathways linking the serotonin transporters (SERT) to depressive disorder: from mechanisms to treatments.

  2025cites this paper
• Role of the microbiota in inflammation-related related psychiatric disorders

  2025cites this paper
• Recent Advances and Future Directions in Alzheimer’s Disease Genetic Research

  2025cites this paper
• The gut microbiome and child and adolescent depression and anxiety: a systematic review and meta-analysis with youth consultation

  2025cites this paper
• Bifidobacterium longum P77 and Lactiplantibacillus plantarum P72 and Their Mix—Live or Heat-Treated—Mitigate Sleeplessness and Depression in Mice: Involvement of Serotonergic and GABAergic Systems

  2025cites this paper
• Bidirectional genetic overlap between mood swings and irritable bowel syndrome.

  2025cites this paper
• The gut microbiome shapes social behaviour across animal species.

  2025cites this paper
• Mental Health Interventions in Everyday Life

  2025cites this paper
• Gut-Brain Interaction: Microbiota and Mental Health

  2025cites this paper
• A disturbed communication between hypothalamic-pituitary-ovary axis and gut microbiota in female infertility: is diet to blame?

  2025cites this paper
• Semen Trigonellae alleviates LPS‐induced depressive behavior via enhancing the abundance of Ligilactobacillus spp.

  2024cites this paper
• Gut feeling: Exploring the intertwined trilateral nexus of gut microbiota, sex hormones, and mental health.

  2024cites this paper
• Lipopolysaccharide-producing Veillonella infantium and Escherichia fergusonii cause vagus nerve-mediated cognitive impairment in mice.

  2024cites this paper
• Bipolar disorder and the gut microbiota: a bibliometric analysis

  2024cites this paper
• Humanistic Health Management and Cancer: Associations of Psychology, Nutrition, and Exercise with Cancer Progression and Pathogenesis

  2024cites this paper
• Perceptions of Mental Health Professionals on Nutritional Psychiatry as an Adjunct Treatment in Mainstream Psychiatric Settings in New South Wales, Australia

  2024cites this paper
• Treatment response of venlafaxine induced alterations of gut microbiota and metabolites in a mouse model of depression

  2024cites this paper
• Exploring the Anti-Inflammatory and Antioxidative Potential of Selenium Nanoparticles Biosynthesized by Lactobacillus casei 393 on an Inflamed Caco-2 Cell Line

  2024cites this paper
• The extracellular vesicle of depressive patient-derived Escherichia fergusonii induces vagus nerve-mediated neuroinflammation in mice

  2024cites this paper
• Microbiota-gut-brain axis and ketogenic diet: how close are we to tackling epilepsy?

  2023cites this paper
• Intestinal microbiota protects against methylmercury-induced neurotoxicity

  2023cites this paper
• The variation characteristics of fecal microbiota in remission UC patients with anxiety and depression

  2023cites this paper
• Gut-brain axis: gut dysbiosis and psychiatric disorders in Alzheimer’s and Parkinson’s disease

  2023cites this paper